GHUCCTS

News

Share This
  • Feb 19, 2021

Request for Applications: 2021-2022 TL1 Translational Biomedical Science Program

Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is now accepting a letter of interest form for its predoctoral student and postdoctoral fellow training program in Translational Biomedical Science (TBS Program). Interest Form DUE April 1, 2021; Final application is DUE June 30, 2021. The TBS program is supported by the NIH TL1 award mechanism and accordingly, follows the same eligibility requirements, stipend structure, and NIH restrictions of Ruth L. Kirschstein National Research Service Awards (NRSA) including F30, F31, F32, and T32 mechanisms.

The goal of the GHUCCTS TBS program is to prepare predoctoral students (PhDs & dual MD-PhDs) and postdoctoral fellows (MDs & PhDs) to become the next generation of leaders in the translation of basic science into improved outcomes for health, aging, and disease. Trainees are taught how to build and lead transdisciplinary collaborative research programs through engaging in dual mentored training experiences in preclinical and clinical research. Students and fellows receive didactic education in human health and disease that takes advantage of existing courses, seminars, and workshops through GHUCCTS-sponsored activities and training programs including the master’s program in Clinical and Translational Science. TBS Scholars are also trained in human subject research methodology & bioethics; grant writing & peer-review; community engagement & team science; negotiation & networking; as well as other career enhancement skills that are tailored to the TBS Scholar’s Individualized Career Development Plan.

The TBS Program capitalizes and expands upon the GHUCCTS established track record in cross-institutional training and research and leverages the rich partnerships that GHUCCTS has established among Georgetown University Medical Center (GUMC), Howard University College of Medicine (HUCM), MedStar Health Research Institute (MHRI), the Washington DC Veterans Affairs Medical Center (DC VAMC) and Oak Ridge National Laboratory (ORNL). The TBS Program provides rich opportunities to study several of the greater Washington, DC area pressing medical problems since GHUCCTS institutions play key roles in multiple aspects of human health in this diverse and predominantly disadvantaged population.

The TBS Program complements existing Ph.D. programs at GU and HU. Students and postdocs interested in complementing their discipline-specific training with supplemental training in translational biomedical science are encouraged to apply.

Applications that propose inter- or multi-disciplinary and collaborative research projects, within the T1-T4 translational research continuum will be considered. We anticipate funding 4 predoctoral students and 4 postdoctoral fellow applications in this cycle. For further details regarding the TL1, visit our website.

Download PDF | Download RFA | Interest Form

Related News

Funding Opportunity: GHUCCTS 2021-2022 Pilot Awards

Mar 29, 2021

GHUCCTS is pleased to announce our 2021-2022 GHUCCTS Pilot Awards application cycle. Applicants must have a full-time faculty appointment at one of the GHUCCTS institutions (Howard, Georgetown, DCVA, Medstar, ORNL). Each application should identify a Contact PI who will be responsible for coordinating and submitting the application. Applications are due Monday, April 19, 2021.

Dr. Veronica Thomas co-authors textbook, named 2021 "Most Promising New Textbook" by TAA

Mar 22, 2021

The Textbook & Academic Authors Association (TAA) recently announced the recipients of their 2021 Textbook Awards. "Evaluation in Today's World:  Respecting Diversity, Improving Quality, and Promoting Usability", co-authored by GHUCCTS Evaluation & Continuous Improvement Director Dr. Veronica Thomas, was one of ten textbooks to receive the "Most Promising New Textbook" award.

Recruitment Innovation Center develops COVID-19 Recruitment + Retention Toolkit

Mar 11, 2021

The Recruitment Innovation Center (RIC) has been heavily involved in multisite COVID-19 trial design and implementation, having consulted on 29 COVID-19 related studies as of this writing. While striving to maintain its values of community engagement, participant-informed methods and scalable design, the RIC has developed new tools and strategies that work in this transformed clinical trial space.

Close